Stockholders’ (Deficit) Equity (Details) - Schedule of Warrant Activity - Warrant [Member] - USD ($) |
6 Months Ended | 12 Months Ended |
---|---|---|
Jun. 30, 2024 |
Dec. 31, 2023 |
|
Schedule of Warrant Activity [Line Items] | ||
Number of warrants, Outstanding balance | 1,240,768 | |
Weighted Average Exercise Price, Outstanding balance | $ 83.98 | |
Weighted Average Remaining Term (in Years), Outstanding balance | 4 years 9 months 18 days | 5 years 1 month 6 days |
Intrinsic Value, Outstanding balance | ||
Number of warrants, Exercisable | 983,473 | |
Weighted Average Exercise Price, Exercisable | $ 105.94 | |
Weighted Average Remaining Term (in Years), Exercisable | 4 years 9 months 18 days | |
Intrinsic Value, Exercisable | ||
Number of Warrants, Exercised | (257,205) | |
Weighted Average Exercise Price, Exercised | $ 0.0019 | |
Intrinsic Value, Exercised | ||
Number of warrants, Outstanding balance | 983,473 | |
Weighted Average Exercise Price, Outstanding balance | $ 105.94 | |
Intrinsic Value, Outstanding balance |
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that exercised during the reporting period. No definition available.
|
X | ||||||||||
- Definition Represents share based payment award non option equity instruments exercisable. No definition available.
|
X | ||||||||||
- Definition Represents share based compensation exercisable intrinsic value. No definition available.
|
X | ||||||||||
- Definition Represents weighted average remaining term exercisable. No definition available.
|
X | ||||||||||
- Definition Represents share based compensation exercised intrinsic value. No definition available.
|
X | ||||||||||
- Definition Represents weighted average exercise price exercisable. No definition available.
|
X | ||||||||||
- Definition Represents weighted average exercise price exercised. No definition available.
|
X | ||||||||||
- Definition Represents weighted average remaining term outstanding balance. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Details
|